Download presentation
Presentation is loading. Please wait.
1
Clinical Trials in IBD
2
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
3
Evolving Treatment Landscape in IBD
4
Conventional Treatments for UC and CD
5
FDA-Approved Biologics for UC and CD
6
UC Treatment Pathway
7
Conventional and Evolving Treatment Strategies for CD
8
Limitations of Current Biologic Treatments for IBD
9
Unmet Therapy Needs in IBD
10
Importance of Randomized, Controlled Trials
11
Challenges in the Current IBD Clinical Trial Environment
12
Evolution of Outcomes Measures in IBD Trials
13
Select Investigational Therapies for UC and CD IL Inhibitors
14
Select Investigational Therapies for UC and CD Other Classes
15
Patient Barriers to Participating in IBD Trials
16
Patient Barriers to Participating in IBD Trials Patient Survey Results
17
Physician Barriers
18
Referring Patients to IBD Trials
19
Participating in an IBD Trial as an Investigator
20
Recruiting and Retaining Patients on Study
21
Novel Trial Designs in IBD
22
Summary and Concluding Remarks
23
Abbreviations
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.